Form D Backcountry SPV Apr 2026
http://archive.fast-edgar.com/20260811/A222V22MX222N2Z2222P22EZ9FTCD2623282
Filed on: August 11, 2026
Form 8-K Theriva Biologics, Inc. For: Aug 11
http://archive.fast-edgar.com/20260811/ABB2262C8Z22NZZ222ZH2ZZZBCBFR2Y2X28Q
Filed on: August 11, 2026
Form 8-K Butterfly Network, Inc. For: Aug 05
0001804176False00018041762026-08-052026-08-050001804176us-gaap:CommonStockMember2026-08-052026-08-05UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPursuant to Section 13 OR 15(d) of theSecurities Exchange Act of 1934Date of Report (Date of earliest event reported): August 5, 2026Butterfly Network, Inc.(Exact name of registrant as specified in its charter)Delaware001-3929284-4618156(State or other jurisdiction ofincorporation)... (continue reading...)
Form 4 MYOMO, INC. For: Aug 07 Filed by: Kovelman Harry
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form 8-K Mereo BioPharma Group For: Aug 11
truefalse0001719714X000-00000000001719714dei:AdrMember2026-08-112026-08-1100017197142026-08-112026-08-110001719714us-gaap:CommonStockMember2026-08-112026-08-11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 11, 2026
MEREO BIOPHARMA GROUP PLC
(Exact name of registrant as specified in its... (continue reading...)
More SEC Filings
View Older Stories-
Form 10-Q Coya Therapeutics, Inc. For: Jun 30
-
Form D IDA Ventures IX a Series
-
Form 8-K ADAMAS TRUST, INC. For: Aug 11
-
Form 8-K ManpowerGroup Inc. For: Aug 07
-
Form 10-Q Prelude Therapeutics For: Jun 30
-
Form 8-K LB PHARMACEUTICALS INC For: Aug 11
-
Form D HINA Liberty Capital
-
Form 8-K Kalaris Therapeutics, For: Aug 11
-
Form 8-K Protara Therapeutics, For: Aug 11
-
Form 8-K Neuronetics, Inc. For: Aug 11
-
Form 424B5 Joby Aviation, Inc.
-
Form 8-K Coya Therapeutics, Inc. For: Aug 11
-
Form 6-K Collective Mining Ltd. For: Aug 11
-
Form 8-K Imunon, Inc. For: Aug 11
-
Form 8-K SMITHFIELD FOODS INC For: Aug 11
-
Form D HOPE ALT 2026 a Series
-
Form 6-K NATIONAL STEEL CO For: Sep 30
-
Form 8-K BIG SKY INDUSTRIAL INC. For: Aug 11
-
Form 8-K 1606 CORP. For: Aug 11
-
Form 8-K HANMI FINANCIAL CORP For: Aug 11
-
Form 10-Q Theravance Biopharma, For: Jun 30
-
Form 10-Q SMITHFIELD FOODS INC For: Jun 28
-
Form 10-Q DPC Holdings PLC For: Jun 28
-
Form 10-Q BIG SKY INDUSTRIAL INC. For: Jun 30
-
Form DEF 14C Sow Good Inc. For: Aug 11
-
Form 8-K Joby Aviation, Inc. For: Aug 08
-
Form 8-K Terrestrial Energy Inc. For: Aug 11
-
Form POS AM Jaguar Health, Inc.
-
Form 1-U Naqi Logix Inc. For: Aug 11
-
Form 8-K Stardust Power Inc. For: Aug 10
-
Form 8-K PEABODY ENERGY CORP For: Aug 11
-
Form 6-K NOVA LTD. For: Aug 11
-
Form 4 MYOMO, INC. For: Aug 07 Filed by: Mitchell Micah
-
Form 8-K Unusual Machines, Inc. For: Aug 10
-
Form SCHEDULE 13D Evogene Ltd. Filed by: RECANATI LEON
-
Form 8-K Prelude Therapeutics For: Aug 11
-
Form SCHEDULE 13D/A DAVION HEALTHCARE PLC Filed by: Kaye Jack Harry
-
Form 6-K NetEase, Inc. For: Aug 11
-
Form 4 MYOMO, INC. For: Aug 07 Filed by: GUDONIS PAUL R
-
Form 6-K Legend Biotech Corp For: Jun 30
-
Form 4 MYOMO, INC. For: Aug 07 Filed by: HENRY DAVID A
-
Form N-PX Asset Value Investors For: Jun 30
-
Form 4 Cooper-Standard Holdings For: Aug 07 Filed by: Kanary MaryAnn Peterson
-
Form 13F-HR Novak & Powell Financial For: Jun 30
-
Form 424B2 HSBC USA INC /MD/
-
Form MA-I/A RSA Advisors, LLC
-
Form MA-I/A AE2S Nexus, LLC
-
Form MA-I/A BAKER TILLY MUNICIPAL
-
Form 6-K TAIWAN SEMICONDUCTOR For: Aug 11
-
Form MA-I/A DIXWORKS LLC
